Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 228 Records) |
Query Trace: Glioma and IDH1[original query] |
---|
Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p/19q codeletion and across IDH mutational status. Cell reports. Medicine 2022 12 4 (1): 100877. Bader Jakob Maximilian, Deigendesch Nikolaus, Misch Martin, Mann Matthias, Koch Arend, Meissner Fel |
Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
A prognostic risk model for glioma patients by systematic evaluation of genomic variations. iScience 2022 12 25 (12): 105681. Zhang Baifeng, Wan Weiqing, Li Zibo, Gao Zhixian, Ji Nan, Xie Jian, Wang Junmei, Wang Bin, Lai-Wan Kwong Dora, Guan Xinyuan, Gao Shengjie, Zhao Yuanli, Lu Youyong, Zhang Liwei, Rodland Karin D, Tsang Shirley |
The role of costimulatory molecules in glioma biology and immune microenvironment. Frontiers in genetics 2022 11 13 1024922. Wang Ji, Wang Zi, Jia Wenxue, Gong Wei, Dong Bokai, Wang Zhuangzhuang, Zhou Meng, Tian Chunl |
MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients. Cancer genetics 2022 11 270-271 22-30. Ferrer V |
The Significance of MGMT Promoter Methylation Status in Diffuse Glioma. International journal of molecular sciences 2022 11 23 (21): . Jovanovi? Nikola, Lazarevi? Milica, Cvetkovi? Vladimir J, Nikolov Vesna, Kosti? Peri? Jelena, Ugrin Milena, Pavlovi? Sonja, Mitrovi? Tatja |
Glioma genetic profiles associated with electrophysiologic hyperexcitability. Neuro-oncology 2023 9 . Steven Tobochnik, Maria Kristina C Dorotan, Hia S Ghosh, Emily Lapinskas, Jayne Vogelzang, David A Reardon, Keith L Ligon, Wenya Linda Bi, Stelios M Smirnakis, Jong Woo L |
Overexpression of ZEB1 and YAP1 is related to poor prognosis in patients with gliomas with different IDH1 status. International journal of clinical and experimental pathology 2023 8 16 (7): 138-149. Na Miao, Zhi-Qiang Wang, Ning Zhang, Zhi-Ping Ma, Li-Ping Su, Yang-Yang Zhai, Yan-Ran Hu, Wei Sang, Wei Zha |
Development and validation of an immune infiltration/tumor proliferation-related Notch3 nomogram for predicting survival in patients with primary glioblastoma. Frontiers in genetics 2023 6 14 1148126. Zong-Qing Zheng, Guo-Guo Zhang, Gui-Qiang Yuan, Jia-Hui Hao, Qian-Qian Nie, Ming-Cheng Zheng, Zhong Wa |
The prognostic impact of subclonal IDH1 mutation in grade 2-4 astrocytomas. Neuro-oncology advances 2023 6 5 (1): vdad069. Meenakshi Vij, Raquel T Yokoda, Omid Rashidipour, Ivy Tran, Varshini Vasudevaraja, Matija Snuderl, Raymund L Yong, William S Cobb, Melissa Umphlett, Jamie M Walker, Nadejda M Tsankova, Timothy E Richards |
Relationship between IDH1/2 and TERT promoter mutation and the prognosis of human glioma patients. Pakistan journal of medical sciences 2023 5 39 (3): 843-847. Xipeng Liu, Ming Liu, Bing Cao, Jianxin Qiao, Xiufeng Zha |
lncRNA TRHDE-AS1 Correlated with Genomic Landscape and Clinical Outcome in Glioma. Genes 2023 5 14 (5): . Jinxuan Xie, Yi Lin, Yajie Li, Aizhong Fang, Xin Li, Songlin Wang, Wenbin |
Identification of Prominent Genes between 3D Glioblastoma Models and Clinical Samples via GEO/TCGA/CGGA Data Analysis. Biology 2023 5 12 (5): . Brandon Wee Siang Phon, Saatheeyavaane Bhuvanendran, Qasim Ayub, Ammu Kutty Radhakrishnan, Muhamad Noor Alfarizal Kamarud |
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence. Brain tumor pathology 2023 3 . Tamura Ryota, Iwanami Akio, Ohara Kentaro, Nishimoto Masaaki, Pareira Eriel Sandika, Miwa Tomoru, Tsuzaki Naoko, Kuranari Yuki, Morimoto Yukina, Toda Masahiro, Okano Hideyuki, Nakamura Masaya, Yoshida Kazunari, Sasaki Hika |
Association between preoperative neurocognitive status and IDH1 mutation status in high-grade gliomas. Neuro-oncology practice 2023 3 10 (2): 132-139. Liouta Evangelia, Kalyvas Aristotelis V, Komaitis Spyridon, Drosos Evangelos, Koutsarnakis Christos, García-Gómez Juan M, Juan-Albarracín Javier, Katsaros Vasileios, Kalamatianos Theodosis, Argyrakos Theodoros, Stranjalis Geor |
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma. Cancer research communications 2023 3 3 (2): 192-201. Fanucci Kristina, Pilat Mary Jo, Shyr Derek, Shyr Yu, Boerner Scott, Li Jing, Durecki Diane, Drappatz Jan, Puduvalli Vinay, Lieberman Frank Scott, Gonzalez Javier, Giglio Pierre, Ivy S Percy, Bindra Ranjit S, Omuro Antonio, LoRusso Patric |
Urinary 8-hydroxy-2'-deoxyguanosine levels are elevated in patients with IDH1-wildtype glioblastoma and are associated with tumor recurrence in gliomas. DNA repair 2023 2 124 103463. Tuna Gamze, Bekar Nazl? Ecem Dal, ??lekel Sertaç, ??lekel Gül Hür |
Identification of a Novel Gene Signature Based on Kinesin Family Members to Predict Prognosis in Glioma. Medicina (Kaunas, Lithuania) 2023 2 59 (2): . Pan Dongxiao, Fang Xixi, Li Jipi |
Diffusion along the perivascular space as a potential biomarker for glioma grading and isocitrate dehydrogenase 1 mutation status prediction. Quantitative imaging in medicine and surgery 2023 12 13 (12): 8259-8273. Hongquan Zhu, Yan Xie, Li Li, Yufei Liu, Shihui Li, Nanxi Shen, Jiaxuan Zhang, Su Yan, Dong Liu, Yuanhao Li, Wenzhen Z |
Clinical Evaluation of IDH Mutation Status in Formalin-Fixed Paraffin-Embedded Tissue in Gliomas. Molecular diagnosis & therapy 2023 1 1-11. Nelson Ernest J, Gubbiotti Maria A, Carlin Alicia M, Nasrallah MacLean P, Van Deerlin Vivianna M, Herlihy Sarah |
Molecular profile and clinical features of patients with gliomas using a broad targeted next generation-sequencing panel. Oncology letters 2023 1 25 (1): 38. Romanidou Ourania, Apostolou Paraskevi, Kouvelakis Kyriakos, Tsangaras Kyriakos, Eliades Alexia, Achilleos Achilleas, Loizides Charalambos, Lemesios Christos, Ioannides Marios, Kypri Elena, Koumbaris George, Papadopoulou Kyriaki, Papathanasiou Athanasios, Rigakos Georgios, Xanthakis Ioannis, Fostira Florentia, Kotoula Vassiliki, Fountzilas George, Patsalis Philippos |
Aberrant HIF1- ? and SIX-1 Expression is Associated with Poor Prognosis in Acute Myeloid Leukemia Patients with Isocitrate Dehydrogenase 1 Mutations. Cancer control : journal of the Moffitt Cancer Center 2024 8 31 10732748241271714. Tariq Ali, Rohma Usman, Syed Alasar Shah, Aamir Parvez, Summayya Anwar, Zahid Muneer, Muhammad Sae |
Tumor-related epilepsy in high-grade glioma: a large series survival analysis. Journal of neuro-oncology 2024 8 . Ryan G Rilinger, Lydia Guo, Akshay Sharma, Josephine Volovetz, Nicolas R Thompson, Matthew Grabowski, Mina Lobbous, Andrew Dhaw |
Comprehensive exploration on the role of base excision repair genes in modulating immune infiltration in low-grade glioma. Pathology, research and practice 2024 8 262 155559. Parthipan P, Subhadra Kumari, Santosh Kumar, Srinivasan Muthuswa |
Clinical outcome, radiological findings, and genetic features of IDH-mutant brainstem glioma in adults. Acta neurochirurgica 2024 6 166 (1): 263. Sogo Oki, Yukitomo Ishi, Ryosuke Sawaya, Michinari Okamoto, Hiroaki Motegi, Zen-Ichi Tanei, Masumi Tsuda, Takashi Mori, Kentaro Nishioka, Hiromi Kanno-Okada, Hidefumi Aoyama, Shinya Tanaka, Shigeru Yamaguchi, Miki Fujimu |
Rapid Tumor DNA Analysis of Cerebrospinal Fluid Accelerates Treatment of Central Nervous System Lymphoma. Blood 2024 5 . Mihir Gupta, Joseph Bradley, Elie Massaad, Evan Burns, N Zeke Georgantas, Garrett Maron, Julie Batten, Aidan Gallagher, Julia Thierauf, Naema Nayyar, Amanda Gordon, SooAe Jones, Michelle Pisapia, Ying Sun, Pamela Stuart Jones, Fred G Barker, William Curry, Rajiv Gupta, Javier Romero, Nancy Wang, Priscilla Brastianos, Maria Martinez-Lage, Kensuke Tateishi, Deborah Anne Forst, Brian Vala Nahed, Tracy T Batchelor, Lauren L Ritterhouse, Florian Iser, Tobias Kessler, Justin T Jordan, Jorg Dietrich, Matthew L Meyerson, Daniel P Cahill, Jochen K Lennerz, Bob Carter, Ganesh M Shank |
IL-6 significantly correlated with the prognosis in low-grade glioma and the mediating effect of immune microenvironment. Medicine 2024 5 103 (19): e38091. Shi-Di Yang, Meng-Zong Chen, Deng-Feng Yang, Shao-Bo Hu, Dong-Dong Zhe |
Pediatric-type high-grade gliomas with PDGFRA amplification in adult patients with Li-Fraumeni syndrome: clinical and molecular characterization of three cases. Acta neuropathologica communications 2024 4 12 (1): 57. Yuji Kibe, Fumiharu Ohka, Kosuke Aoki, Junya Yamaguchi, Kazuya Motomura, Eiji Ito, Kazuhito Takeuchi, Yuichi Nagata, Satoshi Ito, Nobuhiko Mizutani, Yoshiki Shiba, Sachi Maeda, Tomohide Nishikawa, Hiroki Shimizu, Ryuta Sai |
IDH1 mutation predicts seizure occurrence and prognosis in lower-grade glioma adults. Pathology, research and practice 2024 1 254 155165. Ting Tang, Yihe Wang, Yang Dai, Quanlei Liu, Xiaotong Fan, Ye Cheng, Jie Tang, Xinru Xiao, Yongzhi Shan, Penghu Wei, Guoguang Zh |
GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning. Scientific reports 2024 1 14 (1): 2126. Shuhua Zheng, Nikhil Rammohan, Timothy Sita, P Troy Teo, Yilin Wu, Maciej Lesniak, Sean Sachdev, Tarita O Thom |
- Page last reviewed:Feb 1, 2024
- Content source: